🇺🇸 FDA
Patent

US 11866518

Bicyclic peptide ligands specific for TSLP

granted A61KA61K38/00A61K47/545

Quick answer

US patent 11866518 (Bicyclic peptide ligands specific for TSLP) held by BicycleTx Limited expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleTx Limited
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K47/545, A61P, A61P11/00